{"bekendtgoerelseNoegle":{"noticeId":{"value":"9904bf67-2b27-4d51-8ebc-229c9211dc31"},"noticeVersion":{"value":"01"},"noticePublicationNumber":{"value":"00171810-2026"}},"htmlDA":"\n\n \n
1 Køber
1.1 Køber
Officielt navn: Amgros I/S
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktivitet: Sundhed
\n
\n
1.1 Køber
Officielt navn: Sykehusinnkjøp HF, Divisjon legemidler
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktivitet: Sundhed
\n
\n
1.1 Køber
Officielt navn: Landspitali Háskólasjúkrahús
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktivitet: Sundhed
\n
\n
\n
2 Procedure
2.1 Procedure
Titel: Joint Nordic Procurement of Pharmaceuticals 2027 NF2.701.b
\n
Beskrivelse: Denmark, Norway and Iceland have entered into cooperation regarding the procurement\n of pharmaceuticals. The countries will jointly procure and award framework agreements\n in order to ensure the supply of pharmaceuticals in the countries. A framework agreement\n will cover delivery of the pharmaceuticals in all three countries.
However, for\n the lot numbers 1-3 the supplier shall only deliver the pharmaceuticals to Denmark\n and Norway.
In Denmark certain pharmaceuticals are resold to the Faroe Island\n and Greenland. The obligation to deliver the pharmaceuticals in Iceland is subject\n to the precondition that the supplier obtains an exemption regarding printed labels\n and leaflets. If the supplier does not obtain such exemption the agreement will only\n apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix\n 6.
\n
Identifikator for proceduren: 10865a18-abd2-4e05-8082-19235449958e
\n
Udbudsprocedure: Offentligt udbud
\n
Proceduren er en hasteprocedure: nej
\n
2.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
\n
2.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
2.1.3 Værdi
Anslået værdi eksklusiv moms: 65.500.000 Euro
\n
Rammeaftalens maksimumværdi: 65.507.088 Euro
\n
\n
2.1.4 Generelle oplysninger
Yderligere oplysninger: Additional information: The procurement procedure is subject to Danish law and any\n complaints of the procurement procedure shall be lodged with the Danish Complaints\n Board for Public Procurement (Klagenævnet for udbud), see section 5.1.12.

The\n Contracting Authorities have considered whether the tender group could be further\n subdivided. The Contracting Authorities have deemed that this is not the case based\n on the considerations of economies of scale, which will not be realizable with a further\n subdivision as well as costs and patient safety considerations related to the subsequent\n management of contract and pharmaceuticals.

In relation to sections 2.1.3\n and 5.1.5 it should be noted that the estimated value indicated in section 2.1.3 is\n the total estimated value of all lot numbers for the duration of the framework agreement,\n including the option of renewal, see section 5.1.4. Section 5.1.5 sets out the estimated\n value for each lot number, including the option of renewal, see section 5.1.4. The\n value is based on the AIP (\"Apotekernes Indkøbspris\" published by the Danish Medicines\n Agency) of the pharmaceuticals. It should furthermore be noted that the estimated\n value is based on historic consumption data and that the actual purchase under a framework\n agreement may deviate significantly from the estimate, see section 5.1, paragraph\n 5.6 of the tender specifications and clause 4.2 of the framework agreement.

When\n submitting a tender, suppliers must use the European Single Procurement Document (ESPD)\n in the tendering system for the declaration regarding the compulsory grounds for exclusion\n set out in sections 135-136 of the Danish Public Procurement Act (udbudsloven) (the\n Act can be found at www.retsinformation.dk). Further information on the completion\n and application of the ESPD in the tender process is available in the guide drawn\n up by Amgros in this respect and in the \"Instructions for the European Single Procurement\n Document\" drawn up by the Danish Competition and Consumer Authority (Konkurrence og\n Forbrugerstyrelsen). The successful tender(s) to whom the Contracting Authorities\n intend to award the framework agreement must also, before the award, provide documentation\n to the Contracting Authorities regarding the absence of compulsory grounds for exclusion\n as set out in sections 152-153 of the Public Procurement Act. The Contracting Authorities\n are not entitled to exclude a supplier who is subject to one or more of the mandatory\n exclusion grounds set out in sections 135-136 of the Public Procurement Act if the\n supplier has provided sufficient documentation that the supplier is reliable, even\n if the supplier is subject to one or more of the grounds for exclusion set out in\n section138 of the Public Procurement Act. The Contracting Authorities reserve the\n right to carry out a so called \"selfcleaning\" process if relevant. The supplier is\n required to confirm that they do not fall under the exclusion criteria outlined in\n section 134a of the Danish Public Procurement Act. However, they are not required\n to provide documentation to support this confirmation. It is noted that this tender\n falls under Article 5k of Regulation (EU) No. 833/2014, as amended by Regulation (EU)\n 2022/1269, which prohibits the awarding of contracts to Russian companies and Russian\n controlled entities. The contracting authority reserves the right, at any stage of\n the tender process, to demand documentation proving that economic operators are not\n subject to this ban. This may include documentation regarding the location of establishment\n and ownership of the entities involved, as well as any of their subcontractors.
\n
Retsgrundlag:
\n
Direktiv 2014/24/EU
\n
The tender is covered by the Danish Public Procurement Act (No. 10 of 6 January 2023,\n as amended), which implements the Procurement Directive (2014/24/EU).
\n
\n
2.1.5 Tilbudsvilkår
Vilkår for indgivelse:
Det højeste antal delkontrakter, for hvilket en tilbudsgiver kan indgive tilbud: 14
\n
\n
Betingelser for kontraktens udførelse:
Det højeste antal delkontrakter, for hvilket der kan tildeles kontrakter til én tilbudsgiver: 14
\n
\n
\n
2.1.6 Udelukkelsesgrunde
Kilder til grundlag for udelukkelse: Bekendtgørelse
\n
Deltagelse i en kriminel organisation: The Danish Public Procurement Act, §135, section 1, no. 1
\n
Korruption: The Danish Public Procurement Act, §135, section 1, no. 2
\n
Svig: The Danish Public Procurement Act, §135, section 1, no. 3
\n
Terrorhandlinger eller strafbare handlinger med forbindelse til terroraktivitet: The Danish Public Procurement Act, §135, section 1, no. 4
\n
Hvidvaskning af penge eller finansiering af terrorisme: The Danish Public Procurement Act, §135, section 1, no. 5
\n
Børnearbejde og andre former for menneskehandel: The Danish Public Procurement Act, §135, section 1, no. 6
\n
Grunde vedrørende betaling af skatter og afgifter eller bidrag til sociale sikringsordninger: The Danish Public Procurement Act, §135, section 3
\n
Interessekonflikt som følge af deltagelse i udbudsproceduren: The Danish Public Procurement Act, §136, no. 1
\n
Direkte eller indirekte involvering i forberedelsen af denne udbudsprocedure: The Danish Public Procurement Act, §136, no. 2
\n
Afgivelse af urigtige oplysninger, tilbageholdelse af oplysninger, ude af stand til at fremlægge de dokumenter, der anmodes om, eller indhentede fortrolige oplysninger i forbindelse med denne procedure: The Danish Public Procurement Act, §136, no. 3
\n
Alvorlige forsømmelser i forbindelse med udøvelsen af erhvervet: The Danish Public Procurement Act, §136, no. 4
\n
\n
\n
\n
5 Delkontrakt
5.1 Delkontrakt: LOT-0001
Titel: Lot. no. 1
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01AB02 ·\n Generic name: Treosulfan (DK/NO) · Pharmaceutical form: Powder f. infusion fluid ·\n Strength: 1 g · Unit: 10 g ··· ATC Code: L01AB02 · Generic name: Treosulfan (DK/NO)\n · Pharmaceutical form: Powder f. infusion fluid · Strength: 5 g · Unit: 10 g. Under\n the title \"Quantity in units\" listed in the List of Products (Appendix A), an estimated\n consumption of the pharmaceuticals is indicated for each of the countries. It should\n be noted that this estimate corresponds to the historical consumption of the pharmaceuticals\n put up for tender and that suppliers must expect that the actual purchase under a\n framework agreement may deviate significantly from the estimate. Reference is made\n to paragraph 5.6 of the tender specifications and clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 1
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 9.036.848 Euro
\n
Rammeaftalens maksimumværdi: 9.036.848 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0002
Titel: Lot. no. 2
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01BB04 ·\n Generic name: Cladribin (DK/NO) · Pharmaceutical form: Injection Fluid · Strength:\n 2 mg/ml · Unit: 6,3 mg. Under the title \"Quantity in units\" listed in the List of\n Products (Appendix A), an estimated consumption of the pharmaceuticals is indicated\n for each of the countries. It should be noted that this estimate corresponds to the\n historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 2
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 1.594.837 Euro
\n
Rammeaftalens maksimumværdi: 1.594.837 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0003
Titel: Lot. no. 3
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01CA05 ·\n Generic name: Vinflunin (DK/NO) · Pharmaceutical form: Conc. Infusion fluid · Strength:\n 25 mg/ml · Pack size: 2 ml · Unit: 500 mg ··· ATC Code: L01CA05 · Generic name: Vinflunin\n (DK/NO) · Pharmaceutical form: Conc. Infusion fluid · Strength: 25 mg/ml · Pack size:\n 10 ml · Unit: 500 mg. Under the title \"Quantity in units\" listed in the List of Products\n (Appendix A), an estimated consumption of the pharmaceuticals is indicated for each\n of the countries. It should be noted that this estimate corresponds to the historical\n consumption of the pharmaceuticals put up for tender and that suppliers must expect\n that the actual purchase under a framework agreement may deviate significantly from\n the estimate. Reference is made to paragraph 5.6 of the tender specifications and\n clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 3
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 2.040.302 Euro
\n
Rammeaftalens maksimumværdi: 2.040.302 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0004
Titel: Lot. no. 4
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01BA01 ·\n Generic name: Methotrexat (DK/IS/NO) · Pharmaceutical form: Injection Fluid · Strength:\n 25 mg/ml · Unit: 11,429 mg. Under the title \"Quantity in units\" listed in the List\n of Products (Appendix A), an estimated consumption of the pharmaceuticals is indicated\n for each of the countries. It should be noted that this estimate corresponds to the\n historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 4
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 208.577 Euro
\n
Rammeaftalens maksimumværdi: 215.664 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0005
Titel: Lot. no. 5
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01BC01 ·\n Generic name: Cytarabin (DK/IS/NO) · Pharmaceutical form: Injection and Infusion fluid\n · Strength: 20 mg/ml · Unit: 500 mg. Under the title \"Quantity in units\" listed in\n the List of Products (Appendix A), an estimated consumption of the pharmaceuticals\n is indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 5
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 336.088 Euro
\n
Rammeaftalens maksimumværdi: 336.088 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0006
Titel: Lot. no. 6
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01BC01 ·\n Generic name: Cytarabin (DK/IS/NO) · Pharmaceutical form: Injection and Infusion fluid\n · Strength: 100 mg/ml · Pack size: 10 ml · Unit: 500 mg ··· ATC Code: L01BC01 · Generic\n name: Cytarabin (DK/IS/NO) · Pharmaceutical form: Injection and Infusion fluid · Strength:\n 100 mg/ml · Pack size: 20 ml · Unit: 500 mg. Under the title \"Quantity in units\" listed\n in the List of Products (Appendix A), an estimated consumption of the pharmaceuticals\n is indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 6
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 950.534 Euro
\n
Rammeaftalens maksimumværdi: 950.534 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0007
Titel: Lot. no. 7
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01CA02 ·\n Generic name: Vincristin (DK/IS/NO) · Pharmaceutical form: Injection Fluid · Strength:\n 1 mg/ml · Pack size: 2 ml · Unit: 2 mg. Under the title \"Quantity in units\" listed\n in the List of Products (Appendix A), an estimated consumption of the pharmaceuticals\n is indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 7
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 6.557.281 Euro
\n
Rammeaftalens maksimumværdi: 6.557.281 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0008
Titel: Lot. no. 8
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01CE01 ·\n Generic name: Topotecan (DK/IS/NO) · Pharmaceutical form: Conc. Infusion fluid · Strength:\n 1 mg/ml · Pack size: 4 ml · Unit: 2 mg. Under the title \"Quantity in units\" listed\n in the List of Products (Appendix A), an estimated consumption of the pharmaceuticals\n is indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 8
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 296.807 Euro
\n
Rammeaftalens maksimumværdi: 296.807 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0009
Titel: Lot. no. 9
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01CX01 ·\n Generic name: Trabectedin (DK/IS/NO) · Pharmaceutical form: powder f.conc.f.inf.fluid\n · Strength: 0,25 mg/dose · Unit: 2,5 mg ··· ATC Code: L01CX01 · Generic name: Trabectedin\n (DK/IS/NO) · Pharmaceutical form: powder f.conc.f.inf.fluid · Strength: 1 mg/dose\n · Unit: 2,5 mg. Under the title \"Quantity in units\" listed in the List of Products\n (Appendix A), an estimated consumption of the pharmaceuticals is indicated for each\n of the countries. It should be noted that this estimate corresponds to the historical\n consumption of the pharmaceuticals put up for tender and that suppliers must expect\n that the actual purchase under a framework agreement may deviate significantly from\n the estimate. Reference is made to paragraph 5.6 of the tender specifications and\n clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 9
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 14.859.826 Euro
\n
Rammeaftalens maksimumværdi: 14.859.826 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0010
Titel: Lot. no. 10
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01DB02 ·\n Generic name: Daunorubicin (DK/IS/NO) · Pharmaceutical form: Powder f. infusion fluid\n · Strength: 20 mg · Unit: 80 mg. Under the title \"Quantity in units\" listed in the\n List of Products (Appendix A), an estimated consumption of the pharmaceuticals is\n indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 10
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 2.233.789 Euro
\n
Rammeaftalens maksimumværdi: 2.233.789 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0011
Titel: Lot. no. 11
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01DB03 ·\n Generic name: Epirubicin (DK/IS/NO) · Pharmaceutical form: Injection and Infusion\n fluid · Strength: 2 mg/ml · Pack size: 25 ml · Unit: 100 mg ··· ATC Code: L01DB03\n · Generic name: Epirubicin (DK/IS/NO) · Pharmaceutical form: Injection and Infusion\n fluid · Strength: 2 mg/ml · Pack size: 50-100 ml · Unit: 100 mg. Under the title \"Quantity\n in units\" listed in the List of Products (Appendix A), an estimated consumption of\n the pharmaceuticals is indicated for each of the countries. It should be noted that\n this estimate corresponds to the historical consumption of the pharmaceuticals put\n up for tender and that suppliers must expect that the actual purchase under a framework\n agreement may deviate significantly from the estimate. Reference is made to paragraph\n 5.6 of the tender specifications and clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 11
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 15.317.151 Euro
\n
Rammeaftalens maksimumværdi: 15.317.151 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0012
Titel: Lot. no. 12
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01DB06 ·\n Generic name: Idarubicin (DK/IS/NO) · Pharmaceutical form: Injection Fluid · Strength:\n 5 mg · Unit: 20 mg ··· ATC Code: L01DB06 · Generic name: Idarubicin (DK/IS/NO) · Pharmaceutical\n form: Injection Fluid · Strength: 10 mg · Unit: 20 mg. Under the title \"Quantity in\n units\" listed in the List of Products (Appendix A), an estimated consumption of the\n pharmaceuticals is indicated for each of the countries. It should be noted that this\n estimate corresponds to the historical consumption of the pharmaceuticals put up for\n tender and that suppliers must expect that the actual purchase under a framework agreement\n may deviate significantly from the estimate. Reference is made to paragraph 5.6 of\n the tender specifications and clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 12
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 3.784.503 Euro
\n
Rammeaftalens maksimumværdi: 3.784.503 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0013
Titel: Lot. no. 13
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01XX27 ·\n Generic name: Arsentrioxid (DK/IS/NO) · Pharmaceutical form: Conc. Infusion fluid\n · Strength: 1-2 mg/ml · Unit: 7,5 mg. Under the title \"Quantity in units\" listed in\n the List of Products (Appendix A), an estimated consumption of the pharmaceuticals\n is indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Intern ID: Lot. no. 13
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 5.792.915 Euro
\n
Rammeaftalens maksimumværdi: 5.792.915 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
5.1 Delkontrakt: LOT-0014
Titel: Lot. no. 14
\n
Beskrivelse: The following pharmaceuticals are included in the lot number: ATC Code: L01AA09 ·\n Generic name: Bendamustin (DK/IS/NO) · Pharmaceutical form: powder f.conc.f.inf.fluid\n · Strength: 25 mg · Unit: 200 mg ··· ATC Code: L01AA09 · Generic name: Bendamustin\n (DK/IS/NO) · Pharmaceutical form: powder f.conc.f.inf.fluid · Strength: 100 mg · Unit:\n 200 mg. Under the title \"Quantity in units\" listed in the List of Products (Appendix\n A), an estimated consumption of the pharmaceuticals is indicated for each of the countries.\n It should be noted that this estimate corresponds to the historical consumption of\n the pharmaceuticals put up for tender and that suppliers must expect that the actual\n purchase under a framework agreement may deviate significantly from the estimate.\n Reference is made to paragraph 5.6 of the tender specifications and clause 4.2 in\n the framework agreement.
\n
Intern ID: Lot. no. 14
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 33600000 Lægemidler
\n
Valgmuligheder:
Beskrivelse af optioner: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Anslået varighed
Startdato: 01-10-2027
\n
Varigheds slutdato: 30-09-2031
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 2
\n
Yderligere oplysninger om fornyelser: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Værdi
Anslået værdi eksklusiv moms: 2.490.543 Euro
\n
Rammeaftalens maksimumværdi: 2.490.543 Euro
\n
\n
5.1.6 Generelle oplysninger
Dette er et tilbagevendende udbud
\n
Beskrivelse: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Navnene på og de faglige kvalifikationer for det personale, der skal udføre kontrakten, skal angives: Ikke påkrævet
\n
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: -
\n
\n
5.1.7 Strategiske udbud
\n
5.1.9 Udvælgelseskriterier
Kilder til udvælgelseskriterier: Bekendtgørelse
\n
Kriterium: Finansielt forhold
Beskrivelse af udvælgelseskriterium: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Beskrivelse: Pris, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Stability, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 30
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Environment, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 20
\n
\n
\n
Kriterium:
Type: Kvalitet
\n
Beskrivelse: Security of supply, Please refer to section 10 in the tender specifications.
\n
Kategori for tildelingskriteriet vægt: Vægtning (procentdel, præcis)
Tildelingskriterium talværdi: 10
\n
\n
\n
\n
5.1.11 Tilbudsdokumenter
Sprog, som udbudsdokumenterne er officielt tilgængelige på: engelsk
\n
Frist for anmodning om yderligere oplysninger: 01-05-2026 00:00 +02:00
\n
Adresse på udbudsdokumenterne: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Tilbudsvilkår
Vilkår for indgivelse:
Elektronisk indgivelse: Påkrævet
\n
Indgivelsesadresse: https://levportal.amgros.dk/Sider/Default.aspx
\n
Sprog, som tilbud og ansøgninger om deltagelse kan indgives på: engelsk, dansk, norsk, svensk
\n
Elektronisk katalog: Ikke tilladt
\n
Alternative tilbud: Ikke tilladt
\n
Frist for modtagelse af tilbud: 12-05-2026 12:00 +02:00
\n
Varighed, hvor tilbuddet skal forblive gyldigt: 476 Døgn
\n
\n
Oplysninger om offentlig iværksættelse:
Åbningsdato: 12-05-2026 12:00 +02:00
\n
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Yderligere oplysninger: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Betingelser for kontraktens udførelse:
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
Vilkår relateret til kontraktens udførelse: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
Der kræves en fortrolighedsaftale: nej
\n
Elektronisk fakturering: Påkrævet
\n
Der vil blive anvendt elektronisk bestilling: ja
\n
Der vil blive anvendt elektronisk betaling: ja
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Rammeaftale uden fornyet iværksættelse af konkurrence
\n
Det maksimale antal deltagere: 5
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren: Amgros I/S
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der behandler tilbud: Amgros I/S
\n
\n
\n
\n
8 Organisationer
8.1 ORG-0001
Officielt navn: Amgros I/S
\n
Registreringsnummer: 14479880
\n
Postadresse: Dampfærgevej 22  
\n
By: København Ø
\n
Postnummer: 2100
\n
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
E-mail: udbud@amgros.dk
\n
Telefon: 88713000
\n
Internetadresse: http://www.amgros.dk
\n
Adresse til udveksling af oplysninger (URL) (eDelivery-Gateway): https://levportal.amgros.dk/Sider/Default.aspx
\n
Køberprofil: https://levportal.amgros.dk/Sider/Default.aspx
\n
Denne organisations roller:
Køber
Gruppeleder
\n
Indkøbscentral, der rekvirerer vareleverancer og/eller tjenesteydelser tiltænkt andre købere
\n
Indkøbscentral, der tildeler offentlige kontrakter eller indgår rammeaftaler om bygge- og anlægsarbejder, vareindkøb eller tjenesteydelser tiltænkt andre købere
\n
\n
Organisation, der leverer supplerende oplysninger om udbudsproceduren
\n
Organisation, der behandler tilbud
\n
\n
\n
8.1 ORG-0002
Officielt navn: Landspitali Háskólasjúkrahús
\n
Registreringsnummer: 5003002130
\n
Postadresse: Skaftahlíð 24  
\n
By: Reykjavik
\n
Postnummer: IS-105
\n
Landsdel (NUTS): Höfuðborgarsvæði (IS001)
\n
Land: Island
\n
E-mail: loamm@landspitali.is
\n
Telefon: +354 621 8699
\n
Internetadresse: https://island.is/s/rikiskaup
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0003
Officielt navn: Sykehusinnkjøp HF, Divisjon legemidler
\n
Registreringsnummer: 916 879 067
\n
Postadresse: Grev Wedels Plass 7 5. etasje  
\n
By: Oslo
\n
Postnummer: 0151
\n
Landsdel (NUTS): Oslo (NO081)
\n
Land: Norge
\n
E-mail: eirik.sverrisson@sykehusinnkjop.no
\n
Telefon: +957 84 101
\n
Internetadresse: https://www.sykehusinnkjop.no/
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0004
Officielt navn: Klagenævnet for Udbud
\n
Registreringsnummer: 37795526
\n
Postadresse: Nævnenes Hus, Toldboden 2  
\n
By: Viborg
\n
Postnummer: 8800
\n
Landsdel (NUTS): Østjylland (DK042)
\n
Land: Danmark
\n
E-mail: klfu@naevneneshus.dk
\n
Telefon: 72405600
\n
Internetadresse: https://klfu.naevneneshus.dk
\n
Denne organisations roller:
Organisation med ansvar for klager
\n
\n
\n
8.1 ORG-0005
Officielt navn: Konkurrence- og Forbrugerstyrelsen
\n
Registreringsnummer: 10294819
\n
Postadresse: Carl Jacobsens Vej 35  
\n
By: Valby
\n
Postnummer: 2500
\n
Landsdel (NUTS): Københavns omegn (DK012)
\n
Land: Danmark
\n
E-mail: kfst@kfst.dk
\n
Telefon: 41715000
\n
Internetadresse: http://www.kfst.dk
\n
Denne organisations roller:
Organisation, der leverer yderligere oplysninger om klageprocedurerne
\n
\n
\n
\n
Oplysninger om bekendtgørelsen
Bekendtgørelsens ID: 9904bf67-2b27-4d51-8ebc-229c9211dc31 - 01
\n
Formulartype: Konkurrencevilkår
\n
Bekendtgørelsestype: Udbuds- eller koncessionsbekendtgørelse – standardordningen
\n
Afsendelsesdato for bekendtgørelsen: 11-03-2026 00:00 +01:00
\n
Bekendtgørelsens officielle sprog: engelsk 
\n
Bekendtgørelsesnummer: 00171810-2026
\n
EUT-S-nummer: 50/2026
\n
Offentliggørelsesdato: 12-03-2026
\n
\n \n","htmlEN":"\n\n \n
1 Buyer
1.1 Buyer
Official name: Amgros I/S
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Sykehusinnkjøp HF, Divisjon legemidler
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Landspitali Háskólasjúkrahús
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
\n
2 Procedure
2.1 Procedure
Title: Joint Nordic Procurement of Pharmaceuticals 2027 NF2.701.b
\n
Description: Denmark, Norway and Iceland have entered into cooperation regarding the procurement\n of pharmaceuticals. The countries will jointly procure and award framework agreements\n in order to ensure the supply of pharmaceuticals in the countries. A framework agreement\n will cover delivery of the pharmaceuticals in all three countries.
However, for\n the lot numbers 1-3 the supplier shall only deliver the pharmaceuticals to Denmark\n and Norway.
In Denmark certain pharmaceuticals are resold to the Faroe Island\n and Greenland. The obligation to deliver the pharmaceuticals in Iceland is subject\n to the precondition that the supplier obtains an exemption regarding printed labels\n and leaflets. If the supplier does not obtain such exemption the agreement will only\n apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix\n 6.
\n
Procedure identifier: 10865a18-abd2-4e05-8082-19235449958e
\n
Type of procedure: Open
\n
The procedure is accelerated: no
\n
2.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
\n
2.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
2.1.3 Value
Estimated value excluding VAT: 65.500.000 Euro
\n
Maximum value of the framework agreement: 65.507.088 Euro
\n
\n
2.1.4 General information
Additional information: Additional information: The procurement procedure is subject to Danish law and any\n complaints of the procurement procedure shall be lodged with the Danish Complaints\n Board for Public Procurement (Klagenævnet for udbud), see section 5.1.12.

The\n Contracting Authorities have considered whether the tender group could be further\n subdivided. The Contracting Authorities have deemed that this is not the case based\n on the considerations of economies of scale, which will not be realizable with a further\n subdivision as well as costs and patient safety considerations related to the subsequent\n management of contract and pharmaceuticals.

In relation to sections 2.1.3\n and 5.1.5 it should be noted that the estimated value indicated in section 2.1.3 is\n the total estimated value of all lot numbers for the duration of the framework agreement,\n including the option of renewal, see section 5.1.4. Section 5.1.5 sets out the estimated\n value for each lot number, including the option of renewal, see section 5.1.4. The\n value is based on the AIP (\"Apotekernes Indkøbspris\" published by the Danish Medicines\n Agency) of the pharmaceuticals. It should furthermore be noted that the estimated\n value is based on historic consumption data and that the actual purchase under a framework\n agreement may deviate significantly from the estimate, see section 5.1, paragraph\n 5.6 of the tender specifications and clause 4.2 of the framework agreement.

When\n submitting a tender, suppliers must use the European Single Procurement Document (ESPD)\n in the tendering system for the declaration regarding the compulsory grounds for exclusion\n set out in sections 135-136 of the Danish Public Procurement Act (udbudsloven) (the\n Act can be found at www.retsinformation.dk). Further information on the completion\n and application of the ESPD in the tender process is available in the guide drawn\n up by Amgros in this respect and in the \"Instructions for the European Single Procurement\n Document\" drawn up by the Danish Competition and Consumer Authority (Konkurrence og\n Forbrugerstyrelsen). The successful tender(s) to whom the Contracting Authorities\n intend to award the framework agreement must also, before the award, provide documentation\n to the Contracting Authorities regarding the absence of compulsory grounds for exclusion\n as set out in sections 152-153 of the Public Procurement Act. The Contracting Authorities\n are not entitled to exclude a supplier who is subject to one or more of the mandatory\n exclusion grounds set out in sections 135-136 of the Public Procurement Act if the\n supplier has provided sufficient documentation that the supplier is reliable, even\n if the supplier is subject to one or more of the grounds for exclusion set out in\n section138 of the Public Procurement Act. The Contracting Authorities reserve the\n right to carry out a so called \"selfcleaning\" process if relevant. The supplier is\n required to confirm that they do not fall under the exclusion criteria outlined in\n section 134a of the Danish Public Procurement Act. However, they are not required\n to provide documentation to support this confirmation. It is noted that this tender\n falls under Article 5k of Regulation (EU) No. 833/2014, as amended by Regulation (EU)\n 2022/1269, which prohibits the awarding of contracts to Russian companies and Russian\n controlled entities. The contracting authority reserves the right, at any stage of\n the tender process, to demand documentation proving that economic operators are not\n subject to this ban. This may include documentation regarding the location of establishment\n and ownership of the entities involved, as well as any of their subcontractors.
\n
Legal basis:
\n
Directive 2014/24/EU
\n
The tender is covered by the Danish Public Procurement Act (No. 10 of 6 January 2023,\n as amended), which implements the Procurement Directive (2014/24/EU).
\n
\n
2.1.5 Terms of procurement
Terms of submission:
Maximum number of lots for which one tenderer can submit tenders: 14
\n
\n
Terms of contract:
Maximum number of lots for which contracts can be awarded to one tenderer: 14
\n
\n
\n
2.1.6 Grounds for exclusion
Sources of grounds for exclusion: Notice
\n
Participation in a criminal organisation: The Danish Public Procurement Act, §135, section 1, no. 1
\n
Corruption: The Danish Public Procurement Act, §135, section 1, no. 2
\n
Fraud: The Danish Public Procurement Act, §135, section 1, no. 3
\n
Terrorist offences or offences linked to terrorist activities: The Danish Public Procurement Act, §135, section 1, no. 4
\n
Money laundering or terrorist financing: The Danish Public Procurement Act, §135, section 1, no. 5
\n
Child labour and including other forms of trafficking in human beings: The Danish Public Procurement Act, §135, section 1, no. 6
\n
Grounds relating to the payment of taxes or social security contributions : The Danish Public Procurement Act, §135, section 3
\n
Conflict of interest due to its participation in the procurement procedure: The Danish Public Procurement Act, §136, no. 1
\n
Direct or indirect involvement in the preparation of this procurement procedure: The Danish Public Procurement Act, §136, no. 2
\n
Misrepresentation, withheld information, unable to provide required documents or obtained confidential information of this procedure: The Danish Public Procurement Act, §136, no. 3
\n
Grave professional misconduct: The Danish Public Procurement Act, §136, no. 4
\n
\n
\n
\n
5 Lot
5.1 Lot: LOT-0001
Title: Lot. no. 1
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01AB02 ·\n Generic name: Treosulfan (DK/NO) · Pharmaceutical form: Powder f. infusion fluid ·\n Strength: 1 g · Unit: 10 g ··· ATC Code: L01AB02 · Generic name: Treosulfan (DK/NO)\n · Pharmaceutical form: Powder f. infusion fluid · Strength: 5 g · Unit: 10 g. Under\n the title \"Quantity in units\" listed in the List of Products (Appendix A), an estimated\n consumption of the pharmaceuticals is indicated for each of the countries. It should\n be noted that this estimate corresponds to the historical consumption of the pharmaceuticals\n put up for tender and that suppliers must expect that the actual purchase under a\n framework agreement may deviate significantly from the estimate. Reference is made\n to paragraph 5.6 of the tender specifications and clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 1
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 9.036.848 Euro
\n
Maximum value of the framework agreement: 9.036.848 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0002
Title: Lot. no. 2
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01BB04 ·\n Generic name: Cladribin (DK/NO) · Pharmaceutical form: Injection Fluid · Strength:\n 2 mg/ml · Unit: 6,3 mg. Under the title \"Quantity in units\" listed in the List of\n Products (Appendix A), an estimated consumption of the pharmaceuticals is indicated\n for each of the countries. It should be noted that this estimate corresponds to the\n historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 2
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 1.594.837 Euro
\n
Maximum value of the framework agreement: 1.594.837 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0003
Title: Lot. no. 3
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01CA05 ·\n Generic name: Vinflunin (DK/NO) · Pharmaceutical form: Conc. Infusion fluid · Strength:\n 25 mg/ml · Pack size: 2 ml · Unit: 500 mg ··· ATC Code: L01CA05 · Generic name: Vinflunin\n (DK/NO) · Pharmaceutical form: Conc. Infusion fluid · Strength: 25 mg/ml · Pack size:\n 10 ml · Unit: 500 mg. Under the title \"Quantity in units\" listed in the List of Products\n (Appendix A), an estimated consumption of the pharmaceuticals is indicated for each\n of the countries. It should be noted that this estimate corresponds to the historical\n consumption of the pharmaceuticals put up for tender and that suppliers must expect\n that the actual purchase under a framework agreement may deviate significantly from\n the estimate. Reference is made to paragraph 5.6 of the tender specifications and\n clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 3
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 2.040.302 Euro
\n
Maximum value of the framework agreement: 2.040.302 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0004
Title: Lot. no. 4
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01BA01 ·\n Generic name: Methotrexat (DK/IS/NO) · Pharmaceutical form: Injection Fluid · Strength:\n 25 mg/ml · Unit: 11,429 mg. Under the title \"Quantity in units\" listed in the List\n of Products (Appendix A), an estimated consumption of the pharmaceuticals is indicated\n for each of the countries. It should be noted that this estimate corresponds to the\n historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 4
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 208.577 Euro
\n
Maximum value of the framework agreement: 215.664 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0005
Title: Lot. no. 5
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01BC01 ·\n Generic name: Cytarabin (DK/IS/NO) · Pharmaceutical form: Injection and Infusion fluid\n · Strength: 20 mg/ml · Unit: 500 mg. Under the title \"Quantity in units\" listed in\n the List of Products (Appendix A), an estimated consumption of the pharmaceuticals\n is indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 5
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 336.088 Euro
\n
Maximum value of the framework agreement: 336.088 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0006
Title: Lot. no. 6
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01BC01 ·\n Generic name: Cytarabin (DK/IS/NO) · Pharmaceutical form: Injection and Infusion fluid\n · Strength: 100 mg/ml · Pack size: 10 ml · Unit: 500 mg ··· ATC Code: L01BC01 · Generic\n name: Cytarabin (DK/IS/NO) · Pharmaceutical form: Injection and Infusion fluid · Strength:\n 100 mg/ml · Pack size: 20 ml · Unit: 500 mg. Under the title \"Quantity in units\" listed\n in the List of Products (Appendix A), an estimated consumption of the pharmaceuticals\n is indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 6
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 950.534 Euro
\n
Maximum value of the framework agreement: 950.534 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0007
Title: Lot. no. 7
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01CA02 ·\n Generic name: Vincristin (DK/IS/NO) · Pharmaceutical form: Injection Fluid · Strength:\n 1 mg/ml · Pack size: 2 ml · Unit: 2 mg. Under the title \"Quantity in units\" listed\n in the List of Products (Appendix A), an estimated consumption of the pharmaceuticals\n is indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 7
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 6.557.281 Euro
\n
Maximum value of the framework agreement: 6.557.281 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0008
Title: Lot. no. 8
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01CE01 ·\n Generic name: Topotecan (DK/IS/NO) · Pharmaceutical form: Conc. Infusion fluid · Strength:\n 1 mg/ml · Pack size: 4 ml · Unit: 2 mg. Under the title \"Quantity in units\" listed\n in the List of Products (Appendix A), an estimated consumption of the pharmaceuticals\n is indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 8
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 296.807 Euro
\n
Maximum value of the framework agreement: 296.807 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0009
Title: Lot. no. 9
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01CX01 ·\n Generic name: Trabectedin (DK/IS/NO) · Pharmaceutical form: powder f.conc.f.inf.fluid\n · Strength: 0,25 mg/dose · Unit: 2,5 mg ··· ATC Code: L01CX01 · Generic name: Trabectedin\n (DK/IS/NO) · Pharmaceutical form: powder f.conc.f.inf.fluid · Strength: 1 mg/dose\n · Unit: 2,5 mg. Under the title \"Quantity in units\" listed in the List of Products\n (Appendix A), an estimated consumption of the pharmaceuticals is indicated for each\n of the countries. It should be noted that this estimate corresponds to the historical\n consumption of the pharmaceuticals put up for tender and that suppliers must expect\n that the actual purchase under a framework agreement may deviate significantly from\n the estimate. Reference is made to paragraph 5.6 of the tender specifications and\n clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 9
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 14.859.826 Euro
\n
Maximum value of the framework agreement: 14.859.826 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0010
Title: Lot. no. 10
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01DB02 ·\n Generic name: Daunorubicin (DK/IS/NO) · Pharmaceutical form: Powder f. infusion fluid\n · Strength: 20 mg · Unit: 80 mg. Under the title \"Quantity in units\" listed in the\n List of Products (Appendix A), an estimated consumption of the pharmaceuticals is\n indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 10
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 2.233.789 Euro
\n
Maximum value of the framework agreement: 2.233.789 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0011
Title: Lot. no. 11
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01DB03 ·\n Generic name: Epirubicin (DK/IS/NO) · Pharmaceutical form: Injection and Infusion\n fluid · Strength: 2 mg/ml · Pack size: 25 ml · Unit: 100 mg ··· ATC Code: L01DB03\n · Generic name: Epirubicin (DK/IS/NO) · Pharmaceutical form: Injection and Infusion\n fluid · Strength: 2 mg/ml · Pack size: 50-100 ml · Unit: 100 mg. Under the title \"Quantity\n in units\" listed in the List of Products (Appendix A), an estimated consumption of\n the pharmaceuticals is indicated for each of the countries. It should be noted that\n this estimate corresponds to the historical consumption of the pharmaceuticals put\n up for tender and that suppliers must expect that the actual purchase under a framework\n agreement may deviate significantly from the estimate. Reference is made to paragraph\n 5.6 of the tender specifications and clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 11
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 15.317.151 Euro
\n
Maximum value of the framework agreement: 15.317.151 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0012
Title: Lot. no. 12
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01DB06 ·\n Generic name: Idarubicin (DK/IS/NO) · Pharmaceutical form: Injection Fluid · Strength:\n 5 mg · Unit: 20 mg ··· ATC Code: L01DB06 · Generic name: Idarubicin (DK/IS/NO) · Pharmaceutical\n form: Injection Fluid · Strength: 10 mg · Unit: 20 mg. Under the title \"Quantity in\n units\" listed in the List of Products (Appendix A), an estimated consumption of the\n pharmaceuticals is indicated for each of the countries. It should be noted that this\n estimate corresponds to the historical consumption of the pharmaceuticals put up for\n tender and that suppliers must expect that the actual purchase under a framework agreement\n may deviate significantly from the estimate. Reference is made to paragraph 5.6 of\n the tender specifications and clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 12
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 3.784.503 Euro
\n
Maximum value of the framework agreement: 3.784.503 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0013
Title: Lot. no. 13
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01XX27 ·\n Generic name: Arsentrioxid (DK/IS/NO) · Pharmaceutical form: Conc. Infusion fluid\n · Strength: 1-2 mg/ml · Unit: 7,5 mg. Under the title \"Quantity in units\" listed in\n the List of Products (Appendix A), an estimated consumption of the pharmaceuticals\n is indicated for each of the countries. It should be noted that this estimate corresponds\n to the historical consumption of the pharmaceuticals put up for tender and that suppliers\n must expect that the actual purchase under a framework agreement may deviate significantly\n from the estimate. Reference is made to paragraph 5.6 of the tender specifications\n and clause 4.2 in the framework agreement.
\n
Internal identifier: Lot. no. 13
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 5.792.915 Euro
\n
Maximum value of the framework agreement: 5.792.915 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
5.1 Lot: LOT-0014
Title: Lot. no. 14
\n
Description: The following pharmaceuticals are included in the lot number: ATC Code: L01AA09 ·\n Generic name: Bendamustin (DK/IS/NO) · Pharmaceutical form: powder f.conc.f.inf.fluid\n · Strength: 25 mg · Unit: 200 mg ··· ATC Code: L01AA09 · Generic name: Bendamustin\n (DK/IS/NO) · Pharmaceutical form: powder f.conc.f.inf.fluid · Strength: 100 mg · Unit:\n 200 mg. Under the title \"Quantity in units\" listed in the List of Products (Appendix\n A), an estimated consumption of the pharmaceuticals is indicated for each of the countries.\n It should be noted that this estimate corresponds to the historical consumption of\n the pharmaceuticals put up for tender and that suppliers must expect that the actual\n purchase under a framework agreement may deviate significantly from the estimate.\n Reference is made to paragraph 5.6 of the tender specifications and clause 4.2 in\n the framework agreement.
\n
Internal identifier: Lot. no. 14
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33600000 Pharmaceutical products
\n
Options:
Description of the options: Clause 8.2 of the framework agreement provides for an option for delivery in a preagreement\n period (i.e. before the purchase period begins) and an option for delivery in a postagreement\n period (i.e. after the purchase period). The two options may be exercised on the terms\n and conditions stipulated in the framework agreement. The estimated duration in section\n 5.1.3 is including the options for renewals. The framework agreements ordinary duration\n is from 1.10.2027 - 30.9.2029.
\n
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: The procurement is carried out by the central purchasing body Amgros I/S, Landspitali\n in Iceland, and Sykehusinnkjøp HF in Norway.
The delivery locations can be found\n in Appendix 6, 7 and 8 to the Framework Agreement.

The following NUTS codes\n apply to the procurement
DK011 Byen København, DK012 Københavns omegn, DK013 Nordsjælland,\n DK014 Bornholm, DK021 Østsjælland, DK022 Vest- og Sydsjælland, DK031 Fyn, DK032 Sydjylland,\n DK041 Vestjylland, DK042 Østjylland, DK050 Nordjylland, NO011 Oslo, NO012 Akershus,\n NO021 Hedmark, NO022 Oppland, NO031 Østfold, NO032 Buskerud, NO033 Vestfold, NO034\n Telemark, NO041 Aust-Agder, NO042 Vest-Agder, NO043 Rogaland, NO051 Hordaland, NO052\n Sogn og Fjordane, NO053 Møre og Romsdal, NO061 Sør-Trøndelag, NO062 Nord-Trøndelag,\n NO071 Nordland, NO072 Troms, NO073 Finnmark, IS001 Höfuðborgarsvæðið, IS002 Landsbyggð.
\n
\n
5.1.3 Estimated duration
Start date: 01-10-2027
\n
Duration end date: 30-09-2031
\n
\n
5.1.4 Renewal
Maximum renewals: 2
\n
Other information about renewals: The Contracting Authorities shall be entitled to prolong the framework agreement up\n to 2 times for each pharmaceutical on unchanged terms and conditions for up to 12\n months, provided that the Contracting Authorities notifies the supplier of this before\n 1.4.2029, 1.4.2030
\n
\n
5.1.5 Value
Estimated value excluding VAT: 2.490.543 Euro
\n
Maximum value of the framework agreement: 2.490.543 Euro
\n
\n
5.1.6 General information
This is a recurrent procurement
\n
Description: The Contracting Authorities and the Customers continuously purchase pharmaceuticals
\n
Reserved participation: Participation is not reserved.
\n
The names and professional qualifications of the staff assigned to perform the contract must be given: Not required
\n
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: -
\n
\n
5.1.7 Strategic procurement
\n
5.1.9 Selection criteria
Sources of selection criteria: Notice
\n
Criterion: Financial ratio
Description of selection criterion: Financial Relations: This Tender is a public procurement, and there are no minimum\n suitability requirements. Therefore, the criteria 'financial relationship' are not\n applied. However, for systeme technical reasons a note regarding this procurement\n has been included in the description section/collumn.
\n
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Description: Pris, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Stability, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Additional proctetive material, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Environment, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 20
\n
\n
\n
Criterion:
Type: Quality
\n
Description: Security of supply, Please refer to section 10 in the tender specifications.
\n
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 10
\n
\n
\n
\n
5.1.11 Procurement documents
Languages in which the procurement documents are officially available: English
\n
Deadline for requesting additional information: 01-05-2026 00:00 +02:00
\n
Address of the procurement documents: https://levportal.amgros.dk/Sider/Default.aspx
\n
\n
5.1.12 Terms of procurement
Terms of submission:
Electronic submission: Required
\n
Address for submission: https://levportal.amgros.dk/Sider/Default.aspx
\n
Languages in which tenders or requests to participate may be submitted: English, Danish, Norwegian, Swedish
\n
Electronic catalogue: Not allowed
\n
Variants: Not allowed
\n
Deadline for receipt of tenders: 12-05-2026 12:00 +02:00
\n
Duration during which the tender must remain valid: 476 Day
\n
\n
Information about public opening:
Opening date: 12-05-2026 12:00 +02:00
\n
Place: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø
\n
Additional information: Questions concerning the tender documents must be submitted through the tendering\n system, see the provisions of the tender specifications in this regard. The access\n to submit tender requires that the operator is registered as a user of Amgros' tendering\n system. The registration as a user may take a few days, and the tenderer must therefore\n make sure to register in good time. Reference is made to the information provided\n in the tendering system, including the user guide. In relation to section 5.1.12 it\n should be noted that electronic invoicing is required. The Tenderers are not permitted\n to attend the opening of the tenders. Tenders will be registered upon receipt, and\n tenders received on time will be opened collectively after expiry of the deadline\n for submission of tenders. With the notice regarding the tender evaluation, the tenderers\n will receive a comprehensive overview of the operators that have submitted compliant\n tenders.
\n
\n
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
Conditions relating to the performance of the contract: The Supplier must have authorisation to produce, import or receive pharmaceuticals\n for wholesale distribution within the EU/EEA. The Pharmaceuticals shall be included\n in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the\n Norwegian \"Farmalogg\" and the Icelandic “Lyfjaverðskrá” not later than the date listed\n in the tender specifications section 2 in order to ensure supply from the beginning\n of the Purchase Period. The framework agreements are nonexclusive to the supplier.\n The hospitals and health authorities are not obliged to use the framework agreement.
\n
A non-disclosure agreement is required: no
\n
Electronic invoicing: Required
\n
Electronic ordering will be used: yes
\n
Electronic payment will be used: yes
\n
\n
\n
5.1.15 Techniques
Framework agreement:
Framework agreement, without reopening of competition
\n
Maximum number of participants: 5
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no.\n 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:\n Complaints of the tendering procedure must be lodged with the Complaints Board for\n Public Procurement within 6 months after the contracting entity has entered into a\n framework agreement calculated from the day after the day when the contracting entity\n has notified the affected applicants and tenderers, see section 7(2), para.(3) of\n the Act. Not later than at the time of lodging a complaint with the Danish Complaints\n Board for Public Procurement, the complainant must notify the contracting authorities\n in writing that a complaint has been lodged with the Danish Complaints Board for Public\n Procurement and whether the complaint was lodged during the standstill period, see\n section 6(4) of the Act. In cases where the complaint was not lodged within the standstill\n period, the complainant must furthermore indicate whether a suspensory effect of the\n complaint has been requested, see clause 6(4) of the Act.
\n
Organisation providing additional information about the procurement procedure: Amgros I/S
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation processing tenders: Amgros I/S
\n
\n
\n
\n
8 Organisations
8.1 ORG-0001
Official name: Amgros I/S
\n
Registration number: 14479880
\n
Postal address: Dampfærgevej 22  
\n
Town: København Ø
\n
Postcode: 2100
\n
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Email: udbud@amgros.dk
\n
Telephone: 88713000
\n
Internet address: http://www.amgros.dk
\n
Information exchange endpoint (URL): https://levportal.amgros.dk/Sider/Default.aspx
\n
Buyer profile: https://levportal.amgros.dk/Sider/Default.aspx
\n
Roles of this organisation:
Buyer
Group leader
\n
Central purchasing body acquiring supplies and/or services intended for other buyers
\n
Central purchasing body awarding public contracts or concluding framework agreements for works, supplies or services intended for other buyers
\n
\n
Organisation providing additional information about the procurement procedure
\n
Organisation processing tenders
\n
\n
\n
8.1 ORG-0002
Official name: Landspitali Háskólasjúkrahús
\n
Registration number: 5003002130
\n
Postal address: Skaftahlíð 24  
\n
Town: Reykjavik
\n
Postcode: IS-105
\n
Country subdivision (NUTS): Höfuðborgarsvæði (IS001)
\n
Country: Iceland
\n
Email: loamm@landspitali.is
\n
Telephone: +354 621 8699
\n
Internet address: https://island.is/s/rikiskaup
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0003
Official name: Sykehusinnkjøp HF, Divisjon legemidler
\n
Registration number: 916 879 067
\n
Postal address: Grev Wedels Plass 7 5. etasje  
\n
Town: Oslo
\n
Postcode: 0151
\n
Country subdivision (NUTS): Oslo (NO081)
\n
Country: Norway
\n
Email: eirik.sverrisson@sykehusinnkjop.no
\n
Telephone: +957 84 101
\n
Internet address: https://www.sykehusinnkjop.no/
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0004
Official name: Klagenævnet for Udbud
\n
Registration number: 37795526
\n
Postal address: Nævnenes Hus, Toldboden 2  
\n
Town: Viborg
\n
Postcode: 8800
\n
Country subdivision (NUTS): Østjylland (DK042)
\n
Country: Denmark
\n
Email: klfu@naevneneshus.dk
\n
Telephone: 72405600
\n
Internet address: https://klfu.naevneneshus.dk
\n
Roles of this organisation:
Review organisation
\n
\n
\n
8.1 ORG-0005
Official name: Konkurrence- og Forbrugerstyrelsen
\n
Registration number: 10294819
\n
Postal address: Carl Jacobsens Vej 35  
\n
Town: Valby
\n
Postcode: 2500
\n
Country subdivision (NUTS): Københavns omegn (DK012)
\n
Country: Denmark
\n
Email: kfst@kfst.dk
\n
Telephone: 41715000
\n
Internet address: http://www.kfst.dk
\n
Roles of this organisation:
Organisation providing more information on the review procedures
\n
\n
\n
\n
Notice information
Notice identifier/version: 9904bf67-2b27-4d51-8ebc-229c9211dc31 - 01
\n
Form type: Competition
\n
Notice type: Contract or concession notice – standard regime
\n
Notice dispatch date: 11-03-2026 00:00 +01:00
\n
Languages in which this notice is officially available: English 
\n
Notice publication number: 00171810-2026
\n
OJ S issue number: 50/2026
\n
Publication date: 12-03-2026
\n
\n \n","opsummeringDA":{"card":{"titel":"Joint Nordic Procurement of Pharmaceuticals 2027 NF2.701.b","ordregiver":"Amgros I/S ","ordregiverId":"14479880","ordregiverIdDatavasket":"14479880","publiceringsdato":"2026-03-12+01:00","cpvKode":"33600000","cpvTitel":"Lægemidler","formulartype":"Konkurrencevilkår","formulartypeKode":"competition","tidsfrister":["2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00"],"alleOrdregivere":["Amgros I/S ","Landspitali Háskólasjúkrahús ","Sykehusinnkjøp HF, Divisjon legemidler "],"anslaaetVaerdi":"65500000","anslaaetVaerdiValuta":"EUR","beskrivelse":"Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals in the countries. A framework agreement will cover delivery of the pharmaceuticals in all three countries.\nHowever, for the lot numbers 1-3 the supplier shall only deliver the pharmaceuticals to Denmark and Norway. \n In Denmark certain pharmaceuticals are resold to the Faroe Island and Greenland. The obligation to deliver the pharmaceuticals in Iceland is subject to the precondition that the supplier obtains an exemption regarding printed labels and leaflets. If the supplier does not obtain such exemption the agreement will only apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix 6.","bkSubTypeKode":"16","bkSubType":"Udbudsbekendtgørelse – det generelle direktiv, standardordningen","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":["Landspitali Háskólasjúkrahús ","Sykehusinnkjøp HF, Divisjon legemidler "],"udforelsesstedNutsCode":["DK011"],"udforelsesstedSubLand":["Byen København"],"udforelsesstedLand":["Danmark"],"udforelsesstedBy":[],"tilbudsfrister":["2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00"],"intressentfrister":[],"deltagelsefrister":[],"svarfrister":[],"antalParts":0,"antalLots":14,"udbudsDokumenter":["https://levportal.amgros.dk/Sider/Default.aspx"]},"opsummeringEN":{"card":{"titel":"Joint Nordic Procurement of Pharmaceuticals 2027 NF2.701.b","ordregiver":"Amgros I/S ","ordregiverId":"14479880","ordregiverIdDatavasket":"14479880","publiceringsdato":"2026-03-12+01:00","cpvKode":"33600000","cpvTitel":"Pharmaceutical products","formulartype":"Competition","formulartypeKode":"competition","tidsfrister":["2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00"],"alleOrdregivere":["Amgros I/S ","Landspitali Háskólasjúkrahús ","Sykehusinnkjøp HF, Divisjon legemidler "],"anslaaetVaerdi":"65500000","anslaaetVaerdiValuta":"EUR","beskrivelse":"Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals in the countries. A framework agreement will cover delivery of the pharmaceuticals in all three countries.\nHowever, for the lot numbers 1-3 the supplier shall only deliver the pharmaceuticals to Denmark and Norway. \n In Denmark certain pharmaceuticals are resold to the Faroe Island and Greenland. The obligation to deliver the pharmaceuticals in Iceland is subject to the precondition that the supplier obtains an exemption regarding printed labels and leaflets. If the supplier does not obtain such exemption the agreement will only apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix 6.","bkSubTypeKode":"16","bkSubType":"Contract notice – general directive, standard regime","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":["Landspitali Háskólasjúkrahús ","Sykehusinnkjøp HF, Divisjon legemidler "],"udforelsesstedNutsCode":["DK011"],"udforelsesstedSubLand":["Byen København"],"udforelsesstedLand":["Denmark"],"udforelsesstedBy":[],"tilbudsfrister":["2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00","2026-05-12T12:00:00+02:00"],"intressentfrister":[],"deltagelsefrister":[],"svarfrister":[],"antalParts":0,"antalLots":14,"udbudsDokumenter":["https://levportal.amgros.dk/Sider/Default.aspx"]}}